Which of the following drug(s) may cause hypophosphatemia for enterally fed patients?

Hypophosphatemia, or low levels of phosphate in the blood, can occur in enterally fed patients due to various medications that may affect phosphate metabolism or absorption.

Corticosteroids can lead to alterations in renal handling of phosphate and potentially increase urinary phosphate loss. They might also be involved in reducing intestinal absorption of phosphate, especially if there is a high intake of calories without adequate phosphate levels in enteral formulas.

Furosemide, a loop diuretic, has a prominent effect on renal excretion of electrolytes, including phosphate. It can promote the loss of phosphate through urine, which may lead to hypophosphatemia, particularly in patients already at risk.

Sucralfate, commonly used for managing peptic ulcers, can bind to phosphate in the intestines, potentially reducing phosphate absorption. This mechanism can also contribute to lowered blood phosphate levels, especially in enterally fed patients who may have limitations in dietary phosphorus.

Together, all these agents can contribute to the development of hypophosphatemia in enterally fed patients, as they interfere with phosphate balance in the body. Therefore, stating that all of the listed drugs may cause hypophosphatemia is accurate, as they each have mechanisms that can reduce phosphate